Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer

References

• Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin 2007; 57:43 - 66; PMID: 17237035; http://dx.doi.org/10.3322/canjclin.57.1.43
   PubMed Web of Science ®Google Scholar
• Stover TC, Sharma A, Robertson GP, Kester M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 2005; 11:3465 - 3474; PMID: 15867249; http://dx.doi.org/10.1158/1078-0432.CCR-04-1770
   PubMed Web of Science ®Google Scholar
• Jabr-Milane L, van Vlerken L, Devalapally H, Shenoy D, Komareddy S, Bhavsar M, et al. Multi-functional nanocarriers for targeted delivery of drugs and genes. J Control Release 2008; 130:121 - 128; PMID: 18538887; http://dx.doi.org/10.1016/j.jconrel.2008.04.016
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008; 14:1310 - 1316; PMID: 18316549; http://dx.doi.org/10.1158/1078-0432.CCR-07-1441
   PubMed Web of Science ®Google Scholar
• Segui B, Andrieu-Abadie N, Jaffrezou JP, Benoist H, Levade T. Sphingolipids as modulators of cancer cell death: Potential therapeutic targets. Biochim Biophys Acta 2006; 1758:2104 - 2120
   PubMed Web of Science ®Google Scholar
• Taha TA, Hannun YA, Obeid LM. Sphingosine kinase: Biochemical and cellular regulation and role in disease. J Biochem Mol Biol 2006; 39:113 - 131; PMID: 16584625; http://dx.doi.org/10.5483/BMBRep.2006.39.2.113
   PubMedGoogle Scholar
• Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, Hirabayashi Y, et al. A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J 2008; 22:2541 - 2551; PMID: 18245173; http://dx.doi.org/10.1096/fj.07-092981
   PubMed Web of Science ®Google Scholar
• Devalapally H, Duan Z, Seiden MV, Amiji MM. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int J Cancer 2007; 121:1830 - 1838; PMID: 17557285; http://dx.doi.org/10.1002/ijc.22886
   PubMed Web of Science ®Google Scholar
• Alphonse G, Bionda C, Aloy MT, Ardail D, Rousson R, Rodriguez-Lafrasse C. Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels. Oncogene 2004; 23:2703 - 2715; PMID: 15048093; http://dx.doi.org/10.1038/sj.onc.1207357
   PubMed Web of Science ®Google Scholar
• Tran MA, Smith CD, Kester M, Robertson GP. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clin Cancer Res 2008; 14:3571 - 3581; PMID: 18519791; http://dx.doi.org/10.1158/1078-0432.CCR-07-4881
   PubMed Web of Science ®Google Scholar
• Stover T, Kester M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 2003; 307:468 - 475; PMID: 12975495; http://dx.doi.org/10.1124/jpet.103.054056
   PubMed Web of Science ®Google Scholar
• Regala RP, Thompson EA, Fields AP. Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells. Cancer Res 2008; 68:5888 - 5895; PMID: 18632643; http://dx.doi.org/10.1158/0008-5472.CAN-08-0438
   PubMed Web of Science ®Google Scholar
• El-Rayes BF, Ali S, Philip PA, Sarkar FH. Protein kinase C: A target for therapy in pancreatic cancer. Pancreas 2008; 36:346 - 352; PMID: 18437080; http://dx.doi.org/10.1097/MPA.0b013e31815ceaf7
   PubMed Web of Science ®Google Scholar
• Friday BB, Adjei AA. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res 2008; 14:342 - 346; PMID: 18223206; http://dx.doi.org/10.1158/1078-0432.CCR-07-4790
   PubMed Web of Science ®Google Scholar
• Fox TE, Houck KL, O'Neill SM, Nagarajan M, Stover TC, Pomianowski PT, et al. Ceramide recruits and activates protein kinase Czeta (PKCzeta) within structured membrane microdomains. J Biol Chem 2007; 282:12450 - 12457; PMID: 17308302; http://dx.doi.org/10.1074/jbc.M700082200
   PubMed Web of Science ®Google Scholar
• Powell DJ, Hajduch E, Kular G, Hundal HS. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol Cell Biol 2003; 23:7794 - 7808; PMID: 14560023; http://dx.doi.org/10.1128/MCB.23.21.7794-808.2003
   PubMed Web of Science ®Google Scholar
• Bourbon NA, Yun J, Berkey D, Wang Y, Kester M. Inhibitory actions of ceramide upon PKC-epsilon/ERK interactions. Am J Physiol Cell Physiol 2001; 280:1403 - 1411; PMID: 11350735
   PubMed Web of Science ®Google Scholar
• Tagaram HR, Divittore NA, Barth BM, Kaiser JM, Avella D, Kimchi ET, et al. Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma. Gut 2011; 60:695 - 701; PMID: 21193455; http://dx.doi.org/10.1136/gut.2010.216671
   PubMed Web of Science ®Google Scholar
• Liu X, Ryland L, Yang J, Liao A, Aliaga C, Watts R, et al. Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood 2010; 116:4192 - 4201; PMID: 20671121; http://dx.doi.org/10.1182/blood-2010-02271080
   PubMed Web of Science ®Google Scholar
• Nussbaumer P, Hornillos V, Ghobrial M, Ullrich T. An efficient, one-pot synthesis of various ceramide-1-phosphates from sphingosine-1-phosphate. Chem Phys Lipids 2008; 151:125 - 128; PMID: 18039471; http://dx.doi.org/10.1016/j.chemphyslip.2007.10.005
   PubMed Web of Science ®Google Scholar
• Pallis M, Russell N. P-glycoprotein plays a drug-effluxindependent role in augmenting cell survival in acute myeloblastic leukemia and is associated with modulation of a sphingomyelin-ceramide apoptotic pathway. Blood 2000; 95:2897 - 2904; PMID: 10779437
   PubMed Web of Science ®Google Scholar
• Raggers RJ, van Helvoort A, Evers R, van Meer G. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J Cell Sci 1999; 112:415 - 422; PMID: 9885294
   PubMed Web of Science ®Google Scholar
• Chapman JV, Gouaze-Andersson V, Messner MC, Flowers M, Karimi R, Kester M, et al. Metabolism of short-chain ceramide by human cancer cells-implications for therapeutic approaches. Biochem Pharmacol 2010; 80:308 - 315; PMID: 20385104; http://dx.doi.org/10.1016/j.bcp.2010.04.001
   PubMed Web of Science ®Google Scholar
• Réjiba S, Wack S, Aprahamian M, Hajri A. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment. Cancer Sci 2007; 98:1128 - 1136; PMID: 17489984; http://dx.doi.org/10.1111/j.1349-7006.2007.00506.x
   PubMed Web of Science ®Google Scholar
• Christgen M, Schniewind B, Jueschke A, Ungefroren H, Kalthoff H. Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells. Cancer Lett 2005; 227:193 - 200; PMID: 16112422; http://dx.doi.org/10.1016/j.canlet.2005.01.016
   PubMed Web of Science ®Google Scholar
• Hering J, Garrean S, Dekoj TR, Razzak A, Saied A, Trevino J, et al. Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells. Ann Surg Oncol 2007; 14:3620 - 3628; PMID: 17896154; http://dx.doi.org/10.1245/s10434-007-9556-8
   PubMed Web of Science ®Google Scholar
• Jiang PH, Motoo Y, Sawabu N, Minamoto T. Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells. World J Gastroenterol 2006; 12:1597 - 1602; PMID: 16570353
   PubMed Web of Science ®Google Scholar
• Lau JP, Weatherdon KL, Skalski V, Hedley DW. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br J Cancer 2004; 91:1166 - 1173; PMID: 15316562
   PubMed Web of Science ®Google Scholar
• Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. siRNA directed against c-src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity. J Am Coll Surg 2004; 198:953 - 959; PMID: 15194078; http://dx.doi.org/10.1016/j.jamcollsurg.2004.01.037
   PubMed Web of Science ®Google Scholar
• Ishida M, Sunamura M, Furukawa T, Akada M, Fujimura H, Shibuya E, et al. Elucidation of the relationship of BNIP3 expression to gemcitabine chemosensitivity and prognosis. World J Gastroenterol 2007; 13:4593 - 4597; PMID: 17729412
   PubMed Web of Science ®Google Scholar
• Barth BM, Gustafson SJ, Young MM, Fox TE, Shanmugavelandy SS, Kaiser JM, et al. Inhibition of NADPH oxidase by glucosylceramide confers chemoresistance. Cancer Biol Ther 2010; 10:1126 - 1136; PMID: 20935456; http://dx.doi.org/10.4161/cbt.10.11.13438
   PubMed Web of Science ®Google Scholar
• Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 2011; 17:55 - 63; PMID: 21186369; http://dx.doi.org/10.1038/nm.2277
   PubMed Web of Science ®Google Scholar
• Saddoughi SA, Song P, Ogretmen B. Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 2008; 49:413 - 440; PMID: 18751921; http://dx.doi.org/10.1007/978-1-4020-8831-5_16
   PubMedGoogle Scholar
• Dumitru CA, Sandalcioglu IE, Wagner M, Weller M, Gulbins E. Lysosomal ceramide mediates gemcitabine-induced death of glioma cells. J Mol Med 2009; 87:1123 - 1132; PMID: 19763526; http://dx.doi.org/10.1007/s00109-009-0514-8
   PubMed Web of Science ®Google Scholar
• Dumitru CA, Weller M, Gulbins E. Ceramide metabolism determines glioma cell resistance to chemotherapy. J Cell Physiol 2009; 221:688 - 695; PMID: 19711353; http://dx.doi.org/10.1002/jcp.21907
   PubMed Web of Science ®Google Scholar
• Modrak DE, Leon E, Goldenberg DM, Gold DV. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines. Mol Cancer Res 2009; 7:890 - 896; PMID: 19531570; http://dx.doi.org/10.1158/1541-7786.MCR-08-0457
   PubMed Web of Science ®Google Scholar
• Wu BX, Zeidan YH, Hannun YA. Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. Biochim Biophys Acta 2009; 1791:730 - 739; PMID: 19345744
   PubMed Web of Science ®Google Scholar
• Arlt A, Gehrz A, Muerkoster S, Vorndamm J, Kruse ML, Folsch UR, et al. Role of NFkappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003; 22:3243 - 3251; PMID: 12761494; http://dx.doi.org/10.1038/sj.onc.1206390
   PubMed Web of Science ®Google Scholar
• Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM. Mitogenic and antiapoptotic role of constitutive NFkappaB/Rel activity in pancreatic cancer. Int J Cancer 2003; 105:735 - 746; PMID: 12767057; http://dx.doi.org/10.1002/ijc.11081
   PubMed Web of Science ®Google Scholar
• Mortenson MM, Galante JG, Gilad O, Schlieman MG, Virudachalam S, Kung HJ, et al. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. J Cell Biochem 2007; 102:1171 - 1179; PMID: 17960583; http://dx.doi.org/10.1002/jcb.21343
   PubMed Web of Science ®Google Scholar
• Bondar VM, Sweeney-Gotsch B, Andreeff M, Mills GB, McConkey DJ. Inhibition of the phosphatidylinositol-3′-kinase-AKT pathway induces apoptosis in pancreatic carcinoma cells in vitro and in vivo. Mol Cancer Ther 2002; 1:989 - 997; PMID: 12481421
   PubMed Web of Science ®Google Scholar
• Ito D, Fujimoto K, Mori T, Kami K, Koizumi M, Toyoda E, et al. In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer. Int J Cancer 2006; 118:2337 - 2343; PMID: 16331623; http://dx.doi.org/10.1002/ijc.21532
   PubMed Web of Science ®Google Scholar
• Takeda A, Osaki M, Adachi K, Honjo S, Ito H. Role of the phosphatidylinositol-3′-kinase-akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines. Pancreas 2004; 28:353 - 358; PMID: 15084985; http://dx.doi.org/10.1097/00006676200404000-00026
   PubMed Web of Science ®Google Scholar
• Moog R, Burger AM, Brandl M, Schuler J, Schubert R, Unger C, et al. Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. Cancer Chemother Pharmacol 2002; 49:356 - 366; PMID: 11976829; http://dx.doi.org/10.1007/s00280002-0428-4
   PubMed Web of Science ®Google Scholar
• Verheij M, van Blitterswijk WJ, Bartelink H. Radiation-induced apoptosis—the ceramide-SAPK signaling pathway and clinical aspects. Acta Oncol 1998; 37:575 - 581; PMID: 9860316; http://dx.doi.org/10.1080/028418698430287
   PubMed Web of Science ®Google Scholar
• Chmura SJ, Mauceri HJ, Advani S, Heimann R, Beckett MA, Nodzenski E, et al. Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. Cancer Res 1997; 57:4340 - 4347; PMID: 9331096
   PubMed Web of Science ®Google Scholar
• Chmura SJ, Nodzenski E, Beckett MA, Kufe DW, Quintans J, Weichselbaum RR. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res 1997; 57:1270 - 1275; PMID: 9102212
   PubMed Web of Science ®Google Scholar
• Selzner M, Bielawska A, Morse MA, Rudiger HA, Sindram D, Hannun YA, et al. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 2001; 61:1233 - 1240; PMID: 11221856
   PubMed Web of Science ®Google Scholar
• Altinoglu EI, Russin TJ, Kaiser JM, Barth BM, Eklund PC, Kester M, et al. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2008; 2:2075 - 2084; PMID: 19206454; http://dx.doi.org/10.1021/nn800448r
   PubMed Web of Science ®Google Scholar
• Barth BM, Sharma R, Altinoglu EI, Morgan TT, Shanmugavelandy SS, Kaiser JM, et al. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers in vivo. ACS Nano 2010; 4:1279 - 1287; PMID: 20180585; http://dx.doi.org/10.1021/nn901297q
   PubMed Web of Science ®Google Scholar